Upgrade to SI Premium - Free Trial

RBC Capital Reiterates Outperform Rating on Bio-Rad Labs (BIO)

September 28, 2026 9:25 AM
RBC Capital analyst Dan Leonard reiterated an Outperform rating and $390.00 price target on Bio-Rad Labs (NYSE: BIO).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments